Akari Therapeutics, Plc (AKTX)
NASDAQ: AKTX · Real-Time Price · USD
9.88
-0.24 (-2.42%)
At close: Sep 17, 2026, 4:00 PM EDT
9.90
+0.03 (0.25%)
After-hours: Sep 17, 2026, 6:18 PM EDT
Akari Therapeutics, Market Cap
Akari Therapeutics, has a market cap or net worth of $19.23 million as of September 17, 2026. Its market cap has decreased by -21.92% in one year.
Market Cap
19.23M
Enterprise Value
12.23M
1-Year Change
-21.92%
Ranking
Category
Stock Price
$9.88
ChartMarket Cap Chart
Since September 28, 2015, Akari Therapeutics,'s market cap has decreased from $291.48M to $19.23M, a decrease of -93.40%. That is a compound annual growth rate of -21.94%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 17, 2026 | 19.23M | 45.31% |
| Dec 31, 2025 | 13.23M | -59.03% |
| Dec 31, 2024 | 32.30M | 83.11% |
| Dec 29, 2023 | 17.64M | -49.58% |
| Dec 30, 2022 | 34.98M | -51.00% |
| Dec 31, 2021 | 71.40M | 0.31% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Cocrystal Pharma | 22.54M |
| Palatin Technologies | 22.42M |
| PDS Biotechnology | 22.34M |
| Longeveron | 22.06M |
| Lantern Pharma | 21.86M |
| Cellectar Biosciences | 21.83M |
| Jasper Therapeutics | 21.06M |
| GridAI Technologies | 21.03M |